INM vs STZ · rev $4.9M vs P/E 14, rev $9.14B
InMed Pharmaceuticals Inc (INM) versus Constellation Brands Inc Class A (STZ) — a side-by-side from cached financials, not a winner call.
InMed Pharmaceuticals Inc (INM) is a drug manufacturers - specialty & generic company listed on US.
Constellation Brands Inc Class A (STZ) is a beverages - brewers company listed on US.
Latest reported INM revenue for 2025-06-30 was $4.9M. Net income was -$8.2M. INM currently screens at market cap $5.2M.
Latest reported STZ revenue for 2026-02-28 was $9.14B. Net income was $1.69B. Revenue was up 322.3% from 2025-02-28 to 2026-02-28. STZ currently screens at market cap $23.73B and trailing P/E 14.4.
INM currently screens at market cap $5.2M. STZ currently screens at market cap $23.73B and trailing P/E 14.4.
Not investment advice. Open the INM and STZ stock pages for the full models.
Not investment advice.